Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I didn’t say that!! LOL yourself!!
No they don’t do that!!
Thank you!!
What crazy is the PPS is not moving up very much. CRAZY!! A lot of buying lately..Wow!!
What is going on millions and millions of bids filled? Another million is bidding @.054.
Interesting!!
Over 950,000 shares bid @.054. Actually over a million including 100k just filled
The volume is building up. Interesting!!
Why would they want to do that? It doesn’t make any sense.
They have to file it sometimes...doesn’t have to be right away. PLUS THEY HAVE TO BUY SHARES FIRST!
I doubt it. Institutions are not supposed to buy penny stocks. I think insiders are loading.
Another large bid of 572465 @.0501 plus over 620000 @.0500. ACCUMULATION CONTINUES!!!
LOL LOL
NBC 2 news mention VAXART in the news.
https://www.msn.com/en-us/news/us/feds-say-covid-19-vaccine-ready-to-be-deployed-at-warp-speed/ar-BB1bkkyb
So nice to se $7 again!!!!
What if that’s not us? I’m just saying.. it’s definitely a material event and it’s a must to PR it. Money is not a problem. It’s an exciting news if that’s us; I don’t see a reason for him to wait within the three days.
This should make everyone excited like on other message boards!!!
QUOTE:
A couple of pertinent quotes by Paul Mango, Deputy Director, HHS, and agency liaison to Operation Warp Speed;
"It's the same principle we use for vaccines, which is we didn't want to make any investments in manufacturing until we saw early results from trials," Mango said."
"Government could fund research into more vaccines
The United States supports eight vaccine candidates, but Mango said it could invest in more. Any new ones would have to be different from those already funded, he said.
“I would say we have become a little bit more discerning at this point,” he said.
Additional large-scale federal funding would probably go to a vaccine that could be delivered in one dose or orally rather than via injection."
What? What is this has anything to do with ELITE?
VXRT new 24,606 SF building lease details.
By Ron Leuty – Staff Reporter, San Francisco Business Times
Nov 19, 2020, 3:02pm PST
Vaxart Inc. will sublease 24,606 square feet in South San Francisco as it pursues an oral vaccine against Covid-19, the flu and more.
The company said in a Securities and Exchange Commission filing Thursday that it will take space at 170 Harbor Way — near the intersection of East Grand Avenue and Forbes Boulevard — for five years beginning Dec. 1 from Vera Therapeutics Inc. It will pay about $47 per square foot, or nearly $96,000 per month, a significant reduction from the roughly $70-per-square-foot price for new biotech space on the Peninsula. The site is controlled by Healthpeak Properties Inc. (NYSE: PEAK).
Vaxart, which currently leases space on Oyster Point Boulevard in South San Francisco, is one of a handful of companies seeking to develop and produce a vaccine against the coronavirus that causes Covid-19. While other companies' vaccines rely on traditional injections, Vaxart says the vaccine for which it started a human clinical trial last month is designed to be taken by mouth.
The virus has infected more than 56.7 million people globally, including nearly 11.7 million in the United States alone, and killed more than 1.35 million people. The U.S. death toll has eclipsed a quarter-million — more than any other nation.
Vaxart CEO Andrei Floroiu wasn't immediately available to answer if Vaxart plans to maintain its Oyster Point space. The acceleration of interest in potential Covid therapeutics and vaccines has attracted interest from investors and authorities as well. Months before Covid even hit, New York hedge fund Armistice Capital LLC started buying shares of the company for as little as 30 cents, and in June of this year it gained another 20 million shares by exercising warrants and became Vaxart's largest shareholder.
As Covid vaccine interest heightened, Armistice then sold its shares and made a reported $200 million profit. The transactions and Vaxart's involvement or not in the federal government's Operation Warp Speed program brought interest from a grand jury for the U.S. District Court for Northern California in connection with a Justice Department investigation.
The company has said it is cooperating with that investigation and another from the SEC.
Vaxart, which traded for as little as 30 cents in early January and as high as $17.49 in mid-July, It closed Thursday at $5.91 per share.
This drug is such a big deal with the market approximately $1.37 billion market size, why haven’t we heard anything about it from Nasrat? I has not mentioned anywhere and never posted in the pipeline. It’s such a nice surprise and I’m glad!!!!
6 million shares are traded in 3 hours. Glad to see this high volume again. GLTU!
Thanks Makai63!
Do we know how many competitors for this drug? Hey thanks king!
“Elite Pharma got the ANDA approval for Nifedipine.”
Maybe they will announce PR after hour or Monday. Nice find king!
I wouldn’t doubt it.
From what source did you hear it from?
Keep me posted Nasdaq2020, I’m working can only read the messages. TIA!
The stopped losses were taken out IMO.
VANGUARD INCREASED 375.36% TO ITS HOLDING!!!!!!! FOLLOW THE MONEY!!!!
“Vanguard Group Inc reports 375.36% increase in ownership of VXRT / Vaxart, Inc
November 16, 2020 - Vanguard Group Inc has filed a 13F-HR form disclosing ownership of 4,995,186 shares of Vaxart, Inc (US:VXRT) with total holdings valued at $33,217,000 USD as of September 30, 2020. Vanguard Group Inc had filed a previous 13F-HR on August 14, 2020 disclosing 1,050,827 shares of Vaxart, Inc at a value of $9,300,000 USD. This represents a change in shares of 375.36 percent and a change in value of 257.17 percent during the quarter.
Institutional Owners 216
Shares Outstanding 109,469,000 shares
Institutional Shares 41,541,146 - 37.95% (ex 13D/G)”
(fintel.io)
Great post . Thanks N2K
Shorts attack after hour? We just loss all the gain AH lol lol
Yes. Don’t let them lose your fun! The quarter is very good!
These are very good and strong numbers. Number was lower than I expected but again it’s just my speculation as well as anyone else. It will be interesting to see if they feel that is driven by lower market activity due to the pandemic. Let see what Nasrat has for us on his plate tomorrow
Yup. Everyone can speculate, but the real number is very good. CASH FLOW POSITIVE!!!
Based on the good cash flow report? Good luck with that!!!
YES, VERY GOOD QUARTER. Check it out!!!
“Revenue for the quarter was $7.4 million versus 4.6 million last year, an improvement of 2.8 million or 61%. YTD for the six months ended September 30, revenue was 14.9 million versus 8.0 million up 6.9 million or 86% from the prior year
Income from operations improved 1.8 million from PY quarter end from a loss of .5 million to income of 1.3 million
Ytd improvement is $3.8 million from a loss of 1.6 million to income if 2.2 million
Gross profit % is up 172% for the quarter versus 151% ytd
Positive Operating cash flow of $2.7 million.
LOL IT’S NOT EVEN CLOSE!!! About 3/4 more of LAST YEAR IS GOOD!!! I WANT $10 MILLION BUT I WILL TAKE $7.4 MILLION ANYTIME. SORRY ELITE CANT GET YOU RICH YET!!! LOOKS LIKE YOU HAVE TO WAIT A LITTLE BIT MORE. GOT TIME?
Why are you complaining when we had only $4.63 million last year of the same quarter? The last time I check $7.4 million per quarter is a lot better than $4.63 million per quarter. True, we want $10 million but we are still selling drug in the pandemic and $7.4 million imo is a good number no matter how you look at it. Just relax dude!!!
NO, but those little boys still dreaming about it!
Anything above $10,000,000 is GOOD!!!